Initial Prostate Specific Antigen 1.5 ng/ml or Greater in Men 50 Years Old or Younger Predicts Higher Prostate Cancer Risk

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 946-951

  Tang, Ping ^a   Sun, Leon ^a   Uhlman, Matthew A ^a   Robertson, Cary N ^a   Polascik, Thomas J ^a   Albala, David M ^a   Donatucci, Craig F ^a   Moul, Judd W ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

continental population groups; mass screening; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT;

ADULT; AFRICAN AMERICANS; AGE FACTORS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 75849162805     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.021     Document Type: Article

References (17)

1. Andriole G.L., Grubb III R.L., Buys S.S., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 (2009) 1310
2. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320
3. National Comprehensive Cancer Network Clinical Practice Guideline in Oncology. Prostate Cancer Early Detection, version V.2.2007. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf Accessed November 25, 2008
4. Fang J., Metter E.J., Landis P., et al. Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology 58 (2001) 411
5. Antenor J.A., Han M., Roehl K.A., et al. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study. J Urol 172 (2004) 90
6. Loeb S., Nadler R.B., Roehl K.A., et al. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. J Urol 177 (2007) 1745
7. Lane J.A., Howson J., Donovan J.L., et al. Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial. BMJ 335 (2007) 1139
8. Scales Jr. C.D., Antonelli J., Curtis L.H., et al. Prostate-specific antigen screening among young men in the United States. Cancer 113 (2008) 1315
9. Smith C.V., Bauer J.J., Connelly R.R., et al. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol 164 (2000) 1964
10. Khan M.A., Han M., Partin A.W., et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 62 (2003) 86
11. Whittemore A.S., Cirillo P.M., Feldman D., et al. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of black and white Americans. J Urol 174 (2005) 872
12. Roobol M.J., Roobol D.W., and Schroder F.H. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting?. (ERSPC, section Rotterdam). Urology 65 (2005) 343
13. Fowler Jr. J.E., Bigler S.A., Lynch C., et al. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race. Cancer 91 (2001) 1291
14. De Marzo A.M., Marchi V.L., Epstein J.I., et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155 (1999) 1985
15. Winter D.L., Hanlon A.L., Raysor S.L., et al. Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer. Urology 58 (2001) 614
16. Williams H., and Powell I.J. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol 472 (2009) 439
17. Schroder F.H., Roobol-Bouts M., Vis A.N., et al. Prostate-specific antigen-based early detection of prostate cancer-validation of screening without rectal examination. Urology 57 (2001) 83